![Jia Kui Li](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 5 M $ op 30-06-2026
Jia Kui Li worked at Xuanzhu Biopharmaceutical Co., Ltd. from 2018 to 2026 and was Executive Director in 2026.
Dr. Li earned a doctorate from Long Island University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-06-2026 | 3.020.800 ( 0,58% ) | 5 M $ | 30-06-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| XUANZHU BIOPHARMACEUTICAL CO., LTD. | Algemeen Directeur | 05-01-2026 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 2 |
|---|---|
Long Island University
 Long Island University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xuanzhu Biopharmaceutical Co., Ltd.
 Xuanzhu Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development, production and commercialization of drugs for digestive disease, oncology and non-alcoholic steatohepatitis | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau
